Analystreport

Repligen (RGEN) had its price target lowered by UBS Group AG from $200.00 to $195.00. They now have a "buy" rating on the stock.

Repligen Corporation  (RGEN) 
Last repligen corporation earnings: 2/20 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: repligen.com/investors